Did Robert Wittman sell Bristol Myers Squibb stock?

Common questions

Did Robert Wittman sell Bristol Myers Squibb stock?

Yes. Robert Wittman disclosed 1 sale of Bristol Myers Squibb (BMY) stock on Jan 12, 2016, in STOCK Act reports. Added together, the disclosed ranges come to $1K-$15K.

How big were Robert Wittman's Bristol Myers Squibb trades?

STOCK Act reports give a range for each trade, such as $1K-$15K, never an exact amount. Added together, the disclosed ranges come to $1K-$15K.

Did Robert Wittman make these Bristol Myers Squibb trades personally?

Not always. The STOCK Act requires members to report trades by themselves, a spouse and dependent children. The owner column of each linked filing says whose trade it was.

Does Robert Wittman still own Bristol Myers Squibb stock?

This page lists reported trades, not holdings. A purchase can have been sold since, and the filings shown do not say what is held today.

When did Robert Wittman report these trades?

The latest filing is dated Feb 24, 2016. The STOCK Act gives members of Congress 45 days to report a trade, so a filing can trail the trade by weeks. Every row shows both dates.

Where does this data come from?

From periodic transaction reports filed under the STOCK Act with the Clerk of the House. Every trade links to the original filing.